Esaote purchase by Chinese consortium may be blocked by Italian government
The takeover by Italian biomedical company Esaote by a Chinese consortium could be blocked by the Italian government, Italian language daily Il Sole 24 Ore reported. The unsourced report claimed that the government is considering using its "golden power" provisions for enterprises deemed strategic to the national interest to either modify the terms and conditions of the Esaote sale or blocking it entirely.
The report said that a technical examination on the matter has already started.
As previously reported, Esaote has revenues of EUR 270m.